The Venture&Growth strategy focuses on healthtech and therapeutics

Gilde Healthcare differentiates itself through its deep sector knowledge in healthcare, which has been acquired during the past decades. The investment team consisting of industry experts, former scientists and entrepreneurs provides hands-on support to its managers in designing the growth strategy and by contributing domain expertise. Gilde Healthcare believes optimal value creation in healthcare is associated with improved care at lower cost.

The Venture&Growth fund is focused on:

• Healthtech and therapeutics
• Early revenue stage or clinical development stage
• Equity investments of up to €50 million per portfolio company
• Europe and North America
• Significant minority ownership